Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus.

Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus.
Related ArticlesEffects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus. Ther Adv Chronic Dis. 2019;10:2040622319862691 Authors: Onoviran OF, Li D, Toombs Smith S, Raji MA Abstract Elderly patients with diabetes are at high risk of polypharmacy because of multiple coexisting diseases and syndromes. Polypharmacy increases the risk of drug-drug and drug-disease interactions in these ... read more
Source: PubMedPublished on 2019-07-20